White Papers
-
Expedite Study Startup: Four Strategies To Optimize Site Activation
4/11/2022
This white paper will explore four strategies to execute across site selection, training, ethics review, and site initiation.
-
Planned Emergency Research And Exception From Informed Consent
4/5/2022
This white paper focuses on key issues of interest to sponsors who may be interested in planning and designing EFIC studies, sites and investigators conducting EFIC research, and IRBs charged with reviewing EFIC studies.
-
Overcoming Enrollment Challenges In Overcrowded Research Landscape
4/5/2022
The way that we conduct clinical research has been changing since the onset of the pandemic, but a growing number of factors are hindering clinical trial sites from adequately enrolling. Discover the top challenges encountered at sites today and what solutions you can deploy to overcome them.
-
A Novel Approach To Early Phase Studies For Advanced Therapeutics
4/4/2022
Clinical research involving rare disease patients poses a number of questions about patient contact, pre-screening and screening, management, and logistics. This paper explores those questions, as well as the challenges they create, and how they can be addressed.
-
Digital Biomarkers As Endpoints In Parkinson’s Disease
3/30/2022
Gain an in-depth understanding of how digital biomarkers are being developed for this purpose, and an outlook on how advances in technology will drive a shift toward remote data collection in clinical trials.
-
Financial Modeling From Tufts Center For Demonstrates Substantial Net Benefits To Sponsors Who Use Decentralized Clinical Trials Technology
3/30/2022
To develop these insights into the business case for DCTs, researchers conducted a data-driven analysis of the value proposition and return on investment for DCTs using an expected net present value (eNPV) model. Discover the benefits from DCTs that were uncovered in this white paper.
-
The Building Blocks Of DCT: How To Create A Seamless Experience Across eConsent, eCOA And More
3/29/2022
With more than 76% of sponsors seeking to implement decentralized solutions this year, there’s never been more attention given to decentralized trials. Discover why decentralized trials must take a unified approach, one that alleviates burdens for patients and sites in order to drive cost savings and realize efficiencies.
-
Clinical Trial Recruitment
3/29/2022
Gain insight into why study sponsors are motivated to find solutions that optimize enrollment of the right patients from the beginning, and minimize patient dropout after enrollment.
-
The Rise Of Decentralized Clinical Trials
3/29/2022
Discover how technological advancements have created the Internet of Things (IoT), in which numerous devices, including wearables like fitness trackers, can all be connected through software and cloud computing.
-
Tips For Tailoring eConsent For Optimal Patient Centricity
3/29/2022
While informed consent is a critical process for ensuring participant autonomy, consent forms are too long, unclear, difficult to read, and frequently exceed 9th grade reading levels. Explore why eConsent is a potential solution to this problem.